Related Experiment Video
Updated: Mar 6, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Causality-informed models for multidrug-resistant organism prediction: Enabling effective ICU antibiotic stewardship
Linna Wang1, Xinyu Guo2, Yimin Chen3
1College of Computer Science, Sichuan University, Chengdu, Sichuan, China.
Background:
Antimicrobial resistance, particularly from multidrug-resistant organisms (MDROs), remains a global health crisis that escalates clinical and economic burdens. To facilitate effective antibiotic stewardship, identifying causality-informed predictors while accounting for the temporal dependencies of clinical data is essential for developing more robust and actionable predictive models.
Objectives:
This study aims to (1) identify and quantify causality-informed predictors of MDRO, and (2) evaluate the performance of 5 predictive models for MDRO-positive cultures using 2 real-world datasets.
Methods:
We identified causality-informed variables within the Markov boundary of each MDRO to characterize local dependencies. Temporal measurements of these selected variables from the first 24 hours of ICU admission were then combined with static features to predict MDRO culture positivity during ICU stays.
Results:
Across 5 MDRO types, 32 causality-informed features were identified. Validated on MIMIC-IV and MIMIC-III datasets, the Bi-GRU model outperformed competitors, achieving AUROCs of 0.8261-0.8280 and AUPRCs of 0.5227-0.5375 (improving upon XGBoost by up to 1.03% and 25.09%, respectively), while maintaining AUROC >0.75 across all MDRO subtypes. Notably, models trained on the causality-informed reduced feature set performed comparably to or better than those using the full feature set.
Conclusion:
The results highlight the capacity of causality-informed features to reduce spurious correlations. This work offers mechanistic insights to guide ICU antibiotic stewardship.
More Related Videos
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
07:16Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
Related Concept Videos
Pharmacodynamic Models: Overview
Development of Antibiotic Resistance
Antibiotic Selection
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...